Company / Interest Expense
Anixa Biosciences Inc Interest Expense History
FY2014-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$500.5K
FY2018
5-year range
-
FY2014-FY2018
Trend
-3.7%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 5 years, ranging from $451,906 in FY2016 to $1M in FY2015.
Based on SEC 10-K filings.
$500,455 in FY2018 with a 3-year CAGR of -26.6%.
Increased from $451,906 to $500,455 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -26.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -26.6%, indicating a declining trend.
- In FY2018, interest expense decreased 3.7% year-over-year.
- Peak interest expense was recorded in FY2015.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $500.5K | -3.7% |
| FY2017 | $519.9K | +15.1% |
| FY2016 | $451.9K | -64.2% |
| FY2015 | $1.3M | +13.9% |
| FY2014 | $1.1M | +14377.0% |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026